Literature DB >> 31387174

Ac2-26 ameliorates lung ischemia-reperfusion injury via the eNOS pathway.

Jing Gong1, Ying-Nan Ju2, Xue-Ting Wang3, Jing-Li Zhu4, Zhe-Hao Jin5, Wei Gao6.   

Abstract

BACKGROUND: Lung ischemia-reperfusion injury (LIRI) is a major complication after lung transplantation. Annexin A1 (AnxA1) ameliorates inflammation in various injured organs. This study aimed to determine the effects and mechanism of AnxA1 on LIRI after lung transplantation.
METHODS: Thirty-two rats were randomized into sham, saline, Ac2-26 and Ac2-26/L groups. Rats in the saline, Ac2-26 and Ac2-26/L groups underwent left lung transplantation and received saline, Ac2-26, and Ac2-26/L-NIO, respectively. After 24 h of reperfusion, serum and transplanted lung tissues were examined.
RESULTS: The partial pressure of oxygen (PaO2) was increased in the Ac2-26 group compared to that in the saline group but was decreased by L-NIO treatment. In the Ac2-26 group, the wet-to-dry (W/D) weight ratios, total protein concentrations, proinflammatory factors and inducible nitric oxide synthase levels were notably decreased, but the concentrations of anti-inflammatory factors and endothelial nitric oxide synthase levels were significantly increased. Ac2-26 attenuated histological injury and cell apoptosis, and this improvement was reversed by L-NIO.
CONCLUSIONS: Ac2-26 reduced LIRI and improved alveoli-capillary permeability by inhibiting oxygen stress, inflammation and apoptosis. The protective effect of Ac2-26 on LIRI largely depended on the endothelial nitric oxide synthase pathway.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Ac2-26; Annexin A1; Ischemia/reperfusion injury; Lung; Transplantation

Mesh:

Substances:

Year:  2019        PMID: 31387174     DOI: 10.1016/j.biopha.2019.109194

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway.

Authors:  Yingnan Ju; Lin Qiu; Xikun Sun; Hengyu Liu; Wei Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

2.  Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.

Authors:  Xin Xu; Weiwei Gao; Lei Li; Jiheng Hao; Bin Yang; Tao Wang; Long Li; Xuesong Bai; Fanjian Li; Honglei Ren; Meng Zhang; Liyong Zhang; Jiyue Wang; Dong Wang; Jianning Zhang; Liqun Jiao
Journal:  J Neuroinflammation       Date:  2021-05-22       Impact factor: 8.322

3.  Ac2-26 Alleviates Brain Injury after Cardiac Arrest and Cardiopulmonary Resuscitation in Rats via the eNOS Pathway.

Authors:  Jing Gong; Qi-Hang Tai; Guang-Xiao Xu; Xue-Ting Wang; Jing-Li Zhu; Xiao-Qing Zhao; Hai-Bin Sun; Dan Zhu; Wei Gao
Journal:  Mediators Inflamm       Date:  2020-08-18       Impact factor: 4.711

4.  Ac2-26 attenuates hepatic ischemia-reperfusion injury in mice via regulating IL-22/IL-22R1/STAT3 signaling.

Authors:  Wanzhen Li; Hongxin Jiang; Chen Bai; Shuna Yu; Yitong Pan; Chenchen Wang; Huiting Li; Ming Li; Yaxin Sheng; Fangfang Chu; Jie Wang; Yuting Chen; Jianguo Li; Jiying Jiang
Journal:  PeerJ       Date:  2022-09-28       Impact factor: 3.061

5.  Netrin-1 reduces lung ischemia-reperfusion injury by increasing the proportion of regulatory T cells.

Authors:  Zhili Chen; Yuxi Chen; Jue Zhou; Yong Li; Changyao Gong; Xiaobo Wang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

6.  Lipoxin A4 attenuates the lung ischaemia reperfusion injury in rats after lung transplantation.

Authors:  Lijuan Zhang; Qihang Tai; Guangxiao Xu; Wei Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.